Redhill Biopharma Ltd (NASDAQ:RDHL)

U.S. Markets are not yet open, but RDHL is being traded in the pre-market session. Pre-Market quote »
14.84
Delayed Data
As of Apr 27
 +0.14 / +0.95%
Today’s Change
6.89
Today|||52-Week Range
21.00
+11.33%
Year-to-Date

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Redhill Biopharma Ltd have a median target of 27.50, with a high estimate of 30.00 and a low estimate of 23.00. The median estimate represents a +85.31% increase from the last price of 14.84.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Buy stock in Redhill Biopharma Ltd. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.32
Sales
$2.0K
Reporting Date
Apr 30

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 46.11%
 
 
 
 
 
 
Growthannually 15.38%
 
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually -99.86%
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account